US Stock MarketDetailed Quotes
DMKPQ DMK Pharmaceuticals
- 0.040
- +0.008+25.00%
15min DelayClose Jul 11 16:00 ET
403.78KMarket Cap-6P/E (TTM)
0.040High0.030Low16.66KVolume0.030Open0.032Pre Close555.74Turnover0.17%Turnover RatioLossP/E (Static)10.09MShares8.28052wk High-0.08P/B402.10KFloat Cap0.02052wk Low--Dividend TTM10.05MShs Float128501.177Historical High--Div YieldTTM31.25%Amplitude0.020Historical Low0.033Avg Price1Lot Size
About DMK Pharmaceuticals Company
DMK Pharmaceuticals Corp. is a biopharmaceutical company, which engages in the discovery, development, and sale of pharmaceutical, specialty biopharmaceutical, and other drug products. The company provides products in various therapeutic areas, including allergy, respiratory, opioid overdose, and erectile dysfunction markets. It offers the SYMJEPI Injection for the emergency treatment of allergic reactions. The company was founded in June 2006 and is headquartered in San Diego, CA.
Company Profile
SymbolDMKPQ
Company NameDMK Pharmaceuticals
Listing DateAug 14, 1995
Founded2006
CEODr. Ebrahim Versi, M.D.
MarketPink Market
Employees12
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address11682 El Camino Real,Suite 300
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92130
Phone1-858-997-2400
Company Executives
- Name
- Position
- Salary
- Dr. Ebrahim Versi, M.D.
- Chairman of the Board and Chief Executive Officer
- --
- Seth A. Cohen
- Chief Financial Officer
- --
- Jannine C. A. . Versi
- Director
- --
- Dr. Meera J. Desai, PhD
- Independent Director
- 64.00K
- Howard C. Birndorf
- Independent Director
- 64.00K
- Vickie W. Reed
- Independent Director
- 47.18K
- John W. Dorbin, Jr
- General Counsel and Corporate Secretary
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg